TOVX - Synthetic Biologics P/S multiplikatori

Theriva Corp (TOVX) tovar belgisi

GURU.Markets platformasidagi P/S koeffitsiyenti tebranishlari shuni ko'rsatadiki, Theriva Biologics, Inc. (TOVX) kotirovkalari makroiqtisodiyotdan mustaqil qolmoqda, chunki kompaniyaning muvaffaqiyati adenoviral dori vositalari sinovlarining borishiga bog'liq. Yuqori patent marjalari kengayish imkoniyatlarini ta'minlaydi, aktivlar qiymati esa bemorlarning yashab qolish darajasi va texnologiyani himoya qilishga bog'liq. 21.80 qiymati biznesning joriy bozor baholash darajasini ko'rsatadi.

TOVX (Synthetic Biologics) Narxning daromadga nisbati tarixi 08.05.2026dan 17.11.2026gacha

Synthetic Biologics (TOVX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:Theriva Biologics, TOVX
Theriva Biologics Inc ishlab chiqargan mahsulot

Investorlar aktivlarning operatsion kuchini narxning savdoga nisbati (P/S) orqali baholaydilar, bunda past qiymatlar aktivning qadrini past baholashni, shishirilgan raqamlar esa spekulyativ xavfni anglatadi. P/S koeffitsiyenti o'zgarishlarini tahlil qilish orqali Theriva Biologics, Inc. (TOVX) kompaniyasining biznes qiymatini uning akademik R&D yondashuvi samaradorligi va PhD mutaxassislarining xarajatlari bilan bog'lash mumkin, bu esa kompaniyaning fundamental barqarorligini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati ImmunityBio Corp IBRX|Immunocore Holdings - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Janux Corp JANX|RCUS - Narxning daromadga nisbati|ZYME (zymeworks.com) - Kapitalizatsiya va daromad nisbati|Tango Therapeutics Corp (TNGX) - Narxning daromadga nisbati|Sotuvga nisbatan narx Iovance (IOVA)|Kapitalizatsiyaning daromadga nisbati IMTX|XNCR - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati CMPX (Compass Bio)|Kapitalizatsiyaning sotish hajmiga nisbati REPL|P/S multiplikatori LYEL (Lyell Immunopharma, Inc.)|Bozor kapitallashuvining daromadga nisbati IPHA|Pyxis - P/S multiplikatori|Sotuvga nisbatan narx Compugen|IO Biotech, Inc. (IOBT) - Narxning daromadga nisbati|Sutro Biopharma, Inc. - Bozor kapitallashuvining daromadga nisbati|INKT (minktherapeutics.com) - P/S multiplikatori|P/S multiplikatori werewolftx.com|Narxning daromadga nisbati immixbio.com (IMMX)|ALXO: Narxning sotuvga nisbati|P/S multiplikatori CUE (Cue Biopharma Inc.)|PDS Biotechnology (PDSB) - Sotuvga nisbatan narx|SONN - Narxning daromadga nisbati|MAIA Biotechnology, Inc. (MAIA) - Kapitalizatsiyaning daromadga nisbati|LIMN: P/S multiplikatori|LAVA Therapeutics N.V. (LVTX) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati NXTC|P/S multiplikatori leaptx.com|P/S multiplikatori INTS|Narx/daromad koeffitsiyenti Sensei Biotherapeutics, Inc.|Narxning daromadga nisbati gritstonebio.com GRTS|Bozor kapitallashuvining daromadga nisbati KA|NEXI - Narxning daromadga nisbati|Turnstone Biologics Corp. - Kapitalizatsiyaning sotish hajmiga nisbati|VCNX: P/S multiplikatori|Kapitalizatsiya va daromad nisbati HARP